Mabel Ryder, M.D., to serve on NCCN Guidelines Panel
Mabel Ryder, M.D. (ENDO ’15), Division of Endocrinology, Metabolism, Diabetes, Nutrition, and Internal Medicine and Division of Medical Oncology at Mayo Clinic in Rochester, was nominated to serve on the National Comprehensive Cancer Network’s Management of Immunotherapy-Related Toxicity Guidelines Panel.
The National Comprehensive Cancer Network (NCCN) is a nonprofit alliance of leading cancer centers dedicated to improving the quality, effectiveness and efficiency of care for cancer patients.
Dr. Ryder also is an assistant professor of medicine.